Genetic counseling and testing for hereditary hemorrhagic telangiectasia

Shravika Lam, Kelsey S. Guthrie, Muhammad A. Latif, Clifford R. Weiss

Research output: Contribution to journalReview articlepeer-review


Genetic counseling is an important means of identifying a patient's genetic risk of hereditary hemorrhagic telangiectasia (HHT) and assisting patients in making informed decisions about their health. With an increase in understanding of the genetic mechanisms underlying HHT over the last decade, genetic counseling is increasingly being incorporated into the care of patients affected by HHT. In addition to refining the diagnosis of symptomatic patients, genetic testing can help to distinguish asymptomatic, at-risk patients from those who are unaffected by HHT. The purpose of this review article is to summarize the current knowledge regarding the role of genetic counseling and genetic testing in identifying and managing HHT in at-risk populations. This article also reviews the guidelines, outcomes, risks, and challenges of genetic counseling and testing for HHT in various patient populations, and provides an algorithm for the use of genetic counseling in symptomatic and asymptomatic patients.

Original languageEnglish (US)
Pages (from-to)275-284
Number of pages10
JournalClinical Genetics
Issue number3
StatePublished - Mar 2022


  • genetic testing
  • hereditary hemorrhagic telangiectasia
  • interventional radiology
  • vascular anomalies

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics


Dive into the research topics of 'Genetic counseling and testing for hereditary hemorrhagic telangiectasia'. Together they form a unique fingerprint.

Cite this